Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1
暂无分享,去创建一个
F. Zara | M. Piccione | V. Antona | G. Corsello | E. Piro | G. Serra | Clara Giambrone | Luca Lagalla | Vincenzo Antona
[1] L. Garavelli,et al. Patterns of Novel Alleles and Genotype/Phenotype Correlations Resulting from the Analysis of 108 Previously Undetected Mutations in Patients Affected by Neurofibromatosis Type I , 2017, International journal of molecular sciences.
[2] S. Ulusal,et al. Genetic Analyses of the NF1 Gene in Turkish Neurofibromatosis Type I Patients and Definition of three Novel Variants , 2017, Balkan journal of medical genetics : BJMG.
[3] M. Leshno,et al. Predicting neurofibromatosis type 1 risk among children with isolated café‐au‐lait macules , 2017, Journal of the American Academy of Dermatology.
[4] Kimberly J. Johnson,et al. Neurofibromatosis type 1 , 2017, Nature Reviews Disease Primers.
[5] S. Banerjee,et al. Novel phenotypes of NF1 patients from unrelated Chinese families with tibial pseudarthrosis and anemia , 2016, Oncotarget.
[6] Ji Woon Park,et al. Neurofibromatosis Type 1 Accompanied by Craniofacial Pain: Literature Review and Descriptive Case. , 2017, Journal of oral & facial pain and headache.
[7] Á. Hernández-Martín,et al. Neurofibromatosis tipo 1: más que manchas café con leche, efélides y neurofibromas. Parte I. Actualización sobre los criterios dermatológicos diagnósticos de la enfermedad , 2016 .
[8] K. Rauen,et al. Expansion of the RASopathies , 2016, Current Genetic Medicine Reports.
[9] S. Perreault,et al. Café-au-lait Macules and Neurofibromatosis Type 1: A Review of the Literature. , 2016, Pediatric neurology.
[10] A. Duat‐Rodríguez,et al. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots, Freckling, and Neurofibromas. An Update. Part I. Dermatological Clinical Criteria Diagnostic of the Disease. , 2016, Actas dermo-sifiliograficas.
[11] Yiping Shen,et al. Diagnostic value of multiple café‐au‐lait macules for neurofibromatosis 1 in Chinese children , 2016, The Journal of dermatology.
[12] M. Gómez,et al. [Molecular diagnosis as a strategy for differential diagnosis and at early ages of neurofibromatosis type 1 (NF1)]. , 2015, Revista medica de Chile.
[13] R. Ferner,et al. Neurofibromatosis-related tumors: emerging biology and therapies , 2015, Current opinion in pediatrics.
[14] D. Gutmann,et al. Neurofibromatosis type 1: a multidisciplinary approach to care , 2014, The Lancet Neurology.
[15] A. Bolčeková,et al. Thirty‐Nine Novel Neurofibromatosis 1 (NF1) Gene Mutations Identified in Slovak Patients , 2013, Annals of human genetics.
[16] Seon-Yong Jeong,et al. Mutation spectrum of NF1 and clinical characteristics in 78 Korean patients with neurofibromatosis type 1. , 2013, Pediatric neurology.
[17] Y. Zhang,et al. A novel NF1 mutation in a Chinese patient with giant café-au-lait macule in neurofibromatosis type 1 associated with a malignant peripheral nerve sheath tumor and bone abnormality. , 2012, Genetics and molecular research : GMR.
[18] D. Cooper,et al. Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations? , 2012, Human Genomics.
[19] D. Gutmann,et al. Developmental Delays in Children With Neurofibromatosis Type 1 , 2012, Journal of child neurology.
[20] E. Zackai,et al. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome. , 2009, JAMA.
[21] K. Rauen,et al. The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation. , 2009, Current opinion in genetics & development.
[22] G. Neri,et al. A premature infant with Costello syndrome due to a rare G13C HRAS mutation , 2009, American journal of medical genetics. Part A.
[23] B. Korf,et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. , 1997, JAMA.
[24] Harold C. Sox,et al. National Institutes of Health Consensus Development Conference Statement: Geriatric Assessment Methods for Clinical Decision‐making , 1988 .
[25] Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. , 1988, Archives of neurology.